Peter Attia· MD
those methionine and leucine might be two of the more potent activators of the target of rapamycin TOR.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
those methionine and leucine might be two of the more potent activators of the target of rapamycin TOR.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
he basically found a couple amino acids that mattered he found Lucine you know a very common essential Branch chain amino acid an important component of of whey protein for example that people take Arginine a very basic amino acid technically not essential lots of nitrogen in in that amino acid and those were the two big ones that that he found
So we also know that an amino acid you just mentioned a moment ago called leucine is the single most important of all the amino acids at turning up mTor.